Search for: "Novartis AG"
Results 81 - 100
of 440
Sorted by Relevance
|
Sort by Date
19 May 2010, 2:17 pm
Reuters is reporting that a New York jury has awarded $250 million in punitive damages against drugmaker Novartis AG in an employment discrimination class action.The Reuters story says that the jury awarded $3.3 million in compensatory damages to 12 of the plaintiffs, but compensatory damages have not yet been determined for the other 5,588 women in the class.The availability of punitive damages in class actions is a hot topic in punitive damages litigation. [read post]
6 Jul 2010, 12:15 pm
In coverage of today's ruling, Bloomberg News reports that "Novartis AG's Salespeople Covered by Wage Laws, U.S. [read post]
8 Feb 2022, 7:53 am
Both Regeneron and Novartis manufacture versions of their drugs in vials and as a PFS. [read post]
22 Jan 2012, 5:42 pm
Novartis AG said it was advising doctors of new recommendations on using Gilenya. [read post]
16 Sep 2016, 4:07 am
A related issue was whether Novartis Pharma AG (Novartis) was the exclusive licensee of Orion’s 765932 patent and had the right to sue for infringement in these proceedings. [read post]
9 Oct 2015, 7:08 am
Medscape reports that a Food and Drug Administration advisory panel recommended approval of Novartis’ new influenza vaccine “that promises to offer enhanced effectiveness in patients aged over 65 years. [read post]
13 Apr 2014, 9:43 pm
Reddy's Laboratories Ltd. et al. 1:14-cv-00387; filed March 26, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. [read post]
9 Feb 2014, 9:15 pm
Reddy's Laboratories Ltd. et al. 1:14-cv-00157; filed February 5, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. [read post]
8 Feb 2015, 9:59 pm
Roxane Laboratories Inc. 1:15-cv-00128; filed February 5, 2015 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
4 Jan 2015, 9:21 pm
Roxane Laboratories Inc. 1:14-cv-01508; filed December 23, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
28 Dec 2014, 9:49 pm
Par Pharmaceutical Inc. 1:14-cv-01494; filed December 18 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Par Pharmaceutical Inc. [read post]
22 Feb 2015, 9:59 pm
Pfizer, Inc. 2:15-cv-01283; filed February 18, 2015 in the District Court of New Jersey • Plaintiffs: Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG • Defendant: Pfizer, Inc. [read post]
13 Dec 2011, 6:06 am
http://www.businessweek.com/news/2011-12-13/novartis-confirms-patient-died-after-starting-gilenya-drug.html [read post]
23 Mar 2018, 6:49 am
Reuters reports that, breaking “with decisions nationally to the contrary,” the California Supreme Court ruled that consumers can “sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on generic versions of the drugs manufactured by other companies. [read post]
10 Jan 2012, 3:00 am
In 2010, Novartis International AG, a major manufacturer of generic prescription drugs, recorded sales of $46.806 billion. [read post]
6 Aug 2012, 7:55 am
Novartis's complaint alleged that defendants infringed its patent by, among other things, the use of "a commercial gene expression system manufactured by non-party Lonza Group AG . . as a common step in what may otherwise be divergent manufacturing processes. [read post]
23 Sep 2010, 9:36 am
Food and Drug Administration ("FDA") approved Fingolimod capsules (Gilenya, Novartis International AG) for reducing the frequency of relapses and delaying the accumulation of disabling symptoms in relapsing forms of Multiple Sclerosis ("MS"). [read post]
7 Mar 2013, 11:06 am
Novartis AG and UBS AG are two of the multinational companies listed in Switzerland that will be affected by the Minder proposals. [read post]
21 May 2010, 10:18 am
A jury has ordered a Novartis AG pharmaceuticals unit to pay $3.4 million to a dozen women in a gender bias lawsuit. [read post]
4 Mar 2009, 2:47 am
High Court (Administrative Court) Haw, R (on the application of) v Southwark Crown Court & Ors [2009] EWHC 379 (Admin) (03 March 2009) High Court (Patents Court) Novartis AG v Dexcel-Pharma Ltd [2009] EWHC 336 (Pat) (03 March 2009) Source: www.bailii.org [read post]
